title: [Malignant lymphoma (Hodgkin lymphoma and non-Hodgkin lymphoma)].
authors.forename: Tomohiro
authors.initials: T
authors.lastname: Kinoshita
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D000079963:Brentuximab Vedotin; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D006689:Hodgkin Disease / Q000628:therapy; D006801:Humans; D018796:Immunoconjugates / Q000627:therapeutic use; D008224:Lymphoma, Follicular / Q000628:therapy; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy; D016399:Lymphoma, T-Cell / Q000628:therapy; D058990:Molecular Targeted Therapy; D036102:Peripheral Blood Stem Cell Transplantation; D014182:Transplantation, Autologous
chemical_list: D018796:Immunoconjugates; D000079963:Brentuximab Vedotin